Global Pelvic Floor Electric Stimulator Market is expected to grow with the CAGR of 7.76% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-pelvic-floor-electric-stimulator-market
Global pelvic floor electric stimulator market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in global pelvic floor electric stimulator market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.
For instance,
- In October 2020, InControl Medical has launched Regulation D (506c) for Significant Marketing Campaign. It is estimated that this strategy anticipated enhancing company as well as revenue growth of the company in the forecasted period.
Laborie, Inc. is dominating player in global pelvic floor electric stimulator market. The other key players existing in the market includes ATLANTIC THERAPEUTICS, Everyday Medical Instruments Co., Ltd, InControl Medical, The Prometheus Group, Utah Medical Products, Inc., Tic Medizintechnik GmbH & CO. KG, Cleo, Shenzhen XFT Medical Limited, Sugar International, Sunmedix Co, Ltd., Verity Medical Ltd, Novuqare, Relevium Labs Inc., GymnaUniphy, V2U Healthcare among others.
Laborie, Inc.
Laborie, Inc. has headquartered in Utah, U.S. was founded in 1978. The company is a developer, manufacturer and market innovative medical technology and consumables used for the diagnosis and treatment of pelvic health in the Urology, Gynecology, and Colorectal fields as well as gastrointestinal procedures. The product categories offered by the company are Urology & Urogynecology, Gastroenterology, Obstetrics & Gynecology, Neonatal Health, Unisensor Catheters. In which Urology & Urogynecology is the market focused category.
For instance,
- In July 2014, Laborie, Inc. has completed its acquisition of BUCK Elektromedizin GmbH and BUCKmeditec GmbH & Co. Whereas, BUCK develops and distributes innovative and advanced Biofeedback and electrical stimulation equipment, accessories and consumables for pelvic floor dysfunction in the treatment of urinary and fecal incontinence. This acquisition has helped the company for business growth.
The company has presence in North America, South America, Europe, Asia-Pacific, and Middle East and Africa.
Utah Medical Products, Inc.
Utah Medical Products, Inc. headquartered in Minnesota, U.S, was founded in year 1929. The company is engaged in the development, manufacturing and marketing of specialty medical devices with particular interest in healthcare for women and their babies. The products categories of the company are Blood Pressure/Blood Mgt, Electrosurgery, Labor and Delivery, Neonatal Intensive Care, Urological Care, Womens Pelvic Health and OEM/Capabilities. In which Urological Care is the market focused category.
The company has wide global presence across the world as North America, Europe, Asia-Pacific, South America, Middle East and Africa with subsidiaries like Utah Medical Products Ltd (Ireland), Femcare Limited (U.K.), Femcare Australia Pty Ltd (Australia) and Femcare Canada (Canada).
Incontrol Medical
Incontrol Medical headquartered in Wisconsin, U.S, was founded in year 2010. The company is exclusively focusing on designing and manufacturing patented devices for the control of incontinence. The products categories of the company are Bladder Leakage Treatment, Automatic Kegel Exercisers, and Accessories. In which Bladder Leakage Treatment, Automatic Kegel Exercisers are the market focused category.
For instance,
- In October 2020, InControl Medical has launched Regulation D (506c) for Significant Marketing Campaign. It is estimated that this strategy anticipated enhancing company as well as revenue growth of the company in the forecasted period.
The company has wide presence across North America.
